US3853707A - Method for producing hexanor-5,9-seco-pregnan-5-oic acid - Google Patents

Method for producing hexanor-5,9-seco-pregnan-5-oic acid Download PDF

Info

Publication number
US3853707A
US3853707A US00389041A US38904173A US3853707A US 3853707 A US3853707 A US 3853707A US 00389041 A US00389041 A US 00389041A US 38904173 A US38904173 A US 38904173A US 3853707 A US3853707 A US 3853707A
Authority
US
United States
Prior art keywords
hexanor
pregnan
seco
oic acid
fermentation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US00389041A
Other languages
English (en)
Inventor
E Widmer
E Becher
A Schocher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Hoffmann La Roche Inc
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of US3853707A publication Critical patent/US3853707A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00Preparation of steroids
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/863Mycobacterium
    • Y10S435/866Mycobacterium smegmatis

Definitions

  • the present invention relates to a microbiological method for producing 2Obeta-hydr0xy- 9-ox0- 1,2,3,4,10,l9-hexanor-5,9-seco-pregnan-5-oic acid, an
  • the compound of formula I is utilized as an intermediate in the preparation of known steroids by procedures described in Belgian Pat. No. 741,826.
  • Mycobacterium phlei ATCC 19249 it is intended to cover all microorganisms of the genus Mycobacterium phlei which produce the compound of formula land which cannot be definitely differentiated from the strain deposited with the American Type Culture Collection, Rockville, Maryland under ATCC No. 19249 and its subcultures includingmutants and variants.
  • the hexanor-S,9-seco-pregnan-5-oic acid of formula I is manufactured by fermenting 3beta,20betadihydrOXypregn-S-ene or 2Obeta-hydroxypregn-4-en- 3-one with Mycobacterium phlei ATCC 19249 adapted to aliphatic hydrocarbons.
  • the adaption of Mycobacterium phlei ATCC 19249 to aliphatic hydrocarbons can be carried out in a manas the carbon source, the hexanor-S,9-seco-pregnan-5- oic acid of formula I. Those cultures which show no growth on such media are used for the present fermentation.
  • the present process can be carried out by any conventional procedure of aerobic fermentation.
  • suitable culture substrates are liquid media which contain a source of assimilable nitrogen and a source of assimilable carbon as well as inorganic salts.
  • Any conventional source of assimilable nitrogen and assimilablecarbon can be utilized.
  • As the source of assimilable nitrogen there can be used animal, vegetable, microbial and inorganic nitrogen compounds such as meat extracts, peptone, cornsteep, yeast extract, glycine and sodium nitrate.
  • As the source of assimilable carbon there can be used sugars such as glucose and, especially, the steroid starting material to be fermented.
  • the nutrient medium may, if desired, also contain trace elements such as iron, sulfur and phosphorus as well as growth factors (e.g., vitamins such as biotin or pyridoxine) or auxins (e.g., indolylacetic acid).
  • growth factors e.g., vitamins such as biotin or pyridoxine
  • auxins e.g., indolylacetic acid.
  • the medium can be sterilized and/or can be provided with substances such as benzoates, antibiotics, etc., which inhibit the growth of foreign organisms.
  • the fermentation is preferably carried out in a neutral or weakly acidic pI-I-range (e.g.,
  • the fermentation can be carried out at a temperature of between 18C. and 40C. It is preferably carried out at about 28C.
  • the steroid used as the starting material is preferably added to the fermentation culture in solution.
  • Any conventional inert organic solvent can be used as the solvent medium in accordance with this invention.
  • the preferred solvents are included dimethyl sulfoxide, dimethylformamide, ethanol or acetone. It has proved to be advantageous to add the steroid gradually to the fermentation solution and to wait for the complete decomposition of the previously added steroid before each new addition.
  • the hexanor-5,9- seco-pregnan-S-oic acid aforesaid can be isolated from the culture solution by conventional procedures.
  • ner known per se by inoculating the microorganism from culture substrates which contain glucose on to those substrates in which the glucose is replaced in increasing quantity by aliphatic hydrocarbons, especially C -C alkanes.
  • mutants as used herein can be spontaneous' mutants or mutants produced in a physical or chemical manner. Mutants can be produced by irradiation (e.g., with ultraviolet light or gamma rays) or by treatment with mutating agents (e.g., N-methyl-nitronitrosoguanidine or bromouracil). Spontaneous mutants are preferably used in the present process. The selection of the mutants can be carried out by spreading single colonies on agar plates which contain, as the carbon source, the steroid starting material to be fermented. Single colonies obtained from such agar substrates are finally spread on agar plates which contain,
  • Mycobacterium phlei ATCC 19249 adapted to C C n-aIkane, was incoluated from sloping agar cultures on to a culture medium 'of the following composition:
  • the cultures were incubated for days at 28C. with aeration and stirring. From the thus-obtained cultures, there were taken plate-cultures on agar plates which contained only 3B,20B-dihydroxypregn-S-ene as the carbon source. The plate-cultures were repeated several times, by which means the steroid content in the agar plates was increased. Finally, further platecultures were used in which the agar contained only B-hydroxy-9-oxo-l ,2,3,4, 1 0,l9-hexanor-5,9-secopregnan-S-oic acid'as the carbon source. Those cultures which showed no growth on these plates were used for the fermentation. In order to store the cultures, a suspension in sterile 10 percent skim milk was prepared from the biomass and was filled into 2 ml. ampoules and stored under liquid nitrogen.
  • Example 2 in tap water. pH 7.0 (adjusted with sodium hydroxide), was inoculated with the contents of 2 ampoules prepared according to Example 1. The culture was incubated for 48 hours at 28C. with shaking. This preculture .was used to inoculate 8 liters of nutrient medium in a small fermenter following which incubation was carried out for 2 days at 28C. with stirring and aeration (640 r.p.m., 2 liters air/minute), the pH value being adjusted to pH 7.0 by the addition of 28 percent sodium hydroxide. The contents of this fermenter were used as the inoculant for 180 liter fermenter containing the same nutrient solution.
  • pH 7.0 adjusted with sodium hydroxide
  • the fermentation mass was centrifuged, rinsed with 20 liters of water and adjusted to pH 2.0 with concentrated aqueous hydrochloric acid.
  • the solution was extracted twice with the same volume and once with half the volume of methylene chloride.
  • the extracts were concentrated in a rotary evaporator and worked up by countercurrent extractionv
  • the yield of 20,8-hydroxy-9- oxo-1,2,3,4, l0,l9-hexanor-5,9-seco-pregnan-5-oic acid amounted to 82 percent. 10 percent of9,20-dioxo- 1,2,3,4,l0,l9-hexanor-5-seco-pregnan-5-oic acid was also isolated.
  • a solution of 13.4 g of 20beta-hydroxy-9-oxo- 1,2,3,4,1O,19-hexan0r-5,9-seco-pregnan-5oic acid and 4 g of sodium acetate in 250 ml of acetic anhydride is boiled at reflux under nitrogen for 4 hours.
  • the acetic anhydride is removed in vacuum, the residue twice evaporated with toluene and finally taken up in 750 ml of methylene chloride.
  • the methylene chloride solution is washed five times with water, dried over Na SO and evaporated in vacuum.

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
US00389041A 1972-08-31 1973-08-16 Method for producing hexanor-5,9-seco-pregnan-5-oic acid Expired - Lifetime US3853707A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1283872A CH585171A5 (xx) 1972-08-31 1972-08-31

Publications (1)

Publication Number Publication Date
US3853707A true US3853707A (en) 1974-12-10

Family

ID=4386844

Family Applications (1)

Application Number Title Priority Date Filing Date
US00389041A Expired - Lifetime US3853707A (en) 1972-08-31 1973-08-16 Method for producing hexanor-5,9-seco-pregnan-5-oic acid

Country Status (16)

Country Link
US (1) US3853707A (xx)
JP (1) JPS4962692A (xx)
AT (1) AT332001B (xx)
AU (1) AU468583B2 (xx)
BE (1) BE804196A (xx)
CA (1) CA992480A (xx)
CH (1) CH585171A5 (xx)
DE (1) DE2340162A1 (xx)
FR (1) FR2197868B1 (xx)
GB (1) GB1397163A (xx)
HU (1) HU168234B (xx)
IL (1) IL42711A (xx)
NL (1) NL7312061A (xx)
PH (1) PH9700A (xx)
SE (1) SE410731B (xx)
ZA (1) ZA734650B (xx)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4039381A (en) * 1975-11-17 1977-08-02 The Upjohn Company Composition of matter and process
US4042459A (en) * 1975-11-17 1977-08-16 The Upjohn Company Composition of matter and process

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3379621A (en) * 1964-06-12 1968-04-23 Syntex Corp Microbiological preparation of delta1, 3, 5(10)-3-hydroxy steroids
US3616228A (en) * 1968-09-26 1971-10-26 Kurt Schubert Beta-substituted propionic acids and method of making the same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH57A (fr) * 1889-01-08 Richardson Dinsmore John Henry Appareil pour le perfectionnement de la fabrication du gaz d'éclairage
DE1793427A1 (de) * 1968-07-11 1972-02-24 Akad Wissenschaften Ddr Verfahren zur Herstellung von neuen ss-Substituierten Propionsaeuren
CH527147A (de) * 1968-11-19 1972-08-31 Hoffmann La Roche Verfahren zur Herstellung von Indanderivaten

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3379621A (en) * 1964-06-12 1968-04-23 Syntex Corp Microbiological preparation of delta1, 3, 5(10)-3-hydroxy steroids
US3616228A (en) * 1968-09-26 1971-10-26 Kurt Schubert Beta-substituted propionic acids and method of making the same

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4039381A (en) * 1975-11-17 1977-08-02 The Upjohn Company Composition of matter and process
US4042459A (en) * 1975-11-17 1977-08-16 The Upjohn Company Composition of matter and process

Also Published As

Publication number Publication date
ZA734650B (en) 1974-04-24
IL42711A (en) 1976-10-31
AU468583B2 (en) 1976-01-15
ATA752773A (de) 1975-12-15
FR2197868A1 (xx) 1974-03-29
AT332001B (de) 1976-09-10
AU5843173A (en) 1975-01-30
PH9700A (en) 1976-02-19
NL7312061A (xx) 1974-03-04
DE2340162A1 (de) 1974-03-28
CA992480A (en) 1976-07-06
CH585171A5 (xx) 1977-02-28
GB1397163A (en) 1975-06-11
HU168234B (xx) 1976-03-28
SE410731B (sv) 1979-10-29
FR2197868B1 (xx) 1978-02-17
JPS4962692A (xx) 1974-06-18
BE804196A (fr) 1974-02-28

Similar Documents

Publication Publication Date Title
RU2102481C1 (ru) Способ получения 2-кето-l-гулоновой кислоты или ее соли
US3922194A (en) Process for producing 2-keto-L-gulonic acid
US3546073A (en) Fusarium fermentation
US3853707A (en) Method for producing hexanor-5,9-seco-pregnan-5-oic acid
US4366247A (en) Process for preparing tylactone
US4440857A (en) Process for preparing mycarosyltylactone
US4166764A (en) Production of monorden
US3878046A (en) Hydroxylated prostaglandins and process
US3023229A (en) Microbiological aromatization of steroids
US4202819A (en) 2-(3-Alanyl)clavam antibiotic
US3243355A (en) Method of hydroxylating 19-nor-androstenedione
US3751339A (en) Process for preparing chloramphenicol analogues
US3616237A (en) Method of preparing thiogriseofulvins
US4362881A (en) Tylactone
US4036876A (en) 18- AND 19-Hydroxylated prostaglandins
US4870185A (en) Hapalindoles
US3329579A (en) Method of preparing 16-oxygenated derivatives of estr-4-en-3-one
US5229281A (en) Process for production of optically active 3-methyladipic acid from squalene using candida lipolytica
USRE29163E (en) 1,2,3,4,10,19-Hexanor-9-oxo-5,9-seco-25D-spirostan-5-oic acid
US3475275A (en) Method for the production of 3alpha,5-cyclo-6beta,19-oxido-5alpha- androstan-17-one
US3071580A (en) 6beta-hydroxy-16alpha, 17alpha-alkylidendioxy-11-oxygenated pregnenes
US3567583A (en) Fermentative process for the production of ergocristine
US3488258A (en) Method of resolving racemic steroids
US3639212A (en) Process for the preparation of estrane compound by fermentation
US4430429A (en) Production of vitamin B12 -activity substances